Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

BUY
$0.42 - $0.65 $105 - $162
250 Added 33.33%
1,000 $1,000
Q3 2021

Nov 10, 2021

BUY
$2.52 - $2.99 $630 - $747
250 Added 50.0%
750 $2,000
Q1 2021

Jun 17, 2021

SELL
$2.73 - $4.5 $3,316 - $5,467
-1,215 Reduced 70.85%
500 $2,000
Q1 2021

Jun 08, 2021

BUY
$2.73 - $4.5 $4,681 - $7,717
1,715 New
1,715 $2,000

Others Institutions Holding MEIP

# of Institutions
1
Shares Held
2K
Call Options Held
0
Put Options Held
0

About MEI Pharma, Inc.


  • Ticker MEIP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 133,261,000
  • Market Cap $366M
  • Description
  • MEI Pharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of various therapies for the treatment of cancer. The company develops Zandelisib, an oral phosphatidylinositol 3-kinase delta inhibitor that is in Phase III clinical trial for the treatment of patients with relapsed/refractory follicular lymp...
More about MEIP
Track This Portfolio

Track Prentice Wealth Management LLC Portfolio

Follow Prentice Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prentice Wealth Management LLC with notifications on news.